Private equity involvement in California healthcare remains under heightened regulatory scrutiny as the state strengthens protections surrounding physician independence and the corporate practice of medicine. New enforcement authority that took effect in 2026 gives California additional tools to address corporate interference with medical decision-making, placing greater attention on relationships between physician practices, investors, and management organizations.
The issue is particularly significant for physicians operating through professional corporations, management services organizations, or other business arrangements involving outside investors. California’s approach does not prohibit investment in healthcare generally. Instead, the regulatory focus is on whether non-physician entities exercise inappropriate control over clinical decisions or the practice of medicine.
Private Equity Oversight Expands Under California Law
The state’s approach to private equity oversight is closely connected to California’s longstanding corporate practice of medicine restrictions. These rules are intended to preserve physicians’ authority over clinical decisions and prevent business interests from improperly controlling medical care.
Senate Bill 351, sponsored by the California Medical Association, became law after Governor Gavin Newsom signed the measure in October 2025. The legislation strengthened enforcement of California’s corporate practice restrictions and authorized the Attorney General to take action against corporate entities that interfere with the practice of medicine.
The law became part of the healthcare regulatory environment physicians and investors must navigate beginning January 1, 2026.
Physician Independence Remains Central
The central issue surrounding private equity arrangements is not simply who provides financing to a medical practice. California’s regulatory framework focuses on whether outside parties can influence decisions that should remain under physician control.
Clinical decisions involving diagnosis, treatment, referrals, prescribing, and patient management are expected to remain within the professional authority of physicians. Business partners may provide administrative resources, technology, financial services, or other operational support, but those arrangements cannot improperly transfer clinical authority to non-physicians.
This distinction is becoming increasingly important as physician practices evaluate investment and management relationships.
Friendly PC Structures Receive Greater Attention
Professional corporations and so-called friendly-PC arrangements remain an important part of the discussion surrounding private equity and physician practice management. These structures can allow physicians to maintain ownership of the professional medical entity while working with outside management organizations.
However, California regulators and courts are examining whether contractual arrangements give outside parties excessive influence over the physician-owned practice.
The California Medical Association has emphasized that corporate practice of medicine analysis should consider the specific facts and circumstances of each arrangement rather than automatically treating every relationship between physicians and outside organizations as unlawful.
Court Proceedings Could Shape Future Enforcement
The legal environment surrounding private equity and corporate practice restrictions continues evolving through litigation. In April 2026, the California Medical Association filed an amicus brief in Art Center Holdings, Inc. v. WCE CA Art, a case involving a physician-owned professional corporation and a private equity-backed management structure.
The case raises questions about whether particular contractual rights can result in unlawful corporate control of a physician practice. CMA urged the appellate court to use a context-specific approach focused on whether an outside party actually interferes with clinical decision-making.
The outcome could have broader implications for physician practices and management organizations using similar structures.
Management Services Organizations Face Increased Scrutiny
Management services organizations, commonly known as MSOs, can provide physician practices with administrative infrastructure covering areas such as billing, technology, staffing support, purchasing, and business operations.
As private equity investment has become more common in healthcare, some investment-backed practices have relied on MSO structures to separate administrative functions from the professional practice of medicine.
California’s regulatory environment requires these relationships to be carefully structured. Administrative agreements cannot become mechanisms for transferring clinical authority to investors or other non-physician entities.
Physician organizations therefore need to evaluate both the written terms of agreements and how those arrangements operate in practice.
Investors Must Understand Clinical Boundaries
For private equity investors, California’s rules create an important distinction between financial participation and clinical control. Investment strategies may support practice expansion, technology improvements, staffing infrastructure, and administrative modernization, but they must respect the boundaries surrounding physician decision-making.
Investors and management companies evaluating California healthcare opportunities increasingly need legal and compliance review before implementing ownership, governance, or management arrangements.
Understanding the state’s corporate practice requirements can help reduce the risk of structures being challenged after a transaction has already been completed.
Regulatory Changes Affect Practice Transactions
The expansion of private equity oversight may also affect how physician practice transactions are evaluated before closing. Investors, physician owners, and management organizations must consider applicable corporate practice restrictions alongside other healthcare transaction requirements.
This can influence transaction documentation, governance provisions, management agreements, succession arrangements, and decision-making rights.
For physicians considering a partnership or sale, understanding the practical implications of proposed agreements is particularly important. Maintaining clinical independence should be clearly reflected in the structure and operation of the relationship.
Physicians Should Review Existing Agreements
Existing arrangements involving private equity or outside management may also warrant review as California’s enforcement environment develops. Physician practices can evaluate whether contracts preserve appropriate authority over clinical decisions and whether operational provisions inadvertently create concerns under corporate practice restrictions.
Reviewing governance documents, employment agreements, management service agreements, and ownership arrangements can help identify potential areas of concern.
Physicians should also understand how business decisions are separated from clinical responsibilities and ensure that internal processes consistently reflect those boundaries.
Oversight Is Broader Than Investment Alone
California’s regulatory approach to private equity should not be interpreted as a blanket prohibition on outside investment in healthcare. Investment capital can provide resources that allow physician practices to expand services, modernize infrastructure, and improve administrative capabilities.
The central concern is whether financial or corporate interests improperly influence the delivery of medical care.
This distinction allows legitimate business partnerships to continue while giving regulators stronger tools to address arrangements that cross into inappropriate control of medical practice.
Long-Term Outlook for Private Equity
The long-term outlook for private equity in California healthcare will depend increasingly on regulatory compliance, transaction transparency, and the ability of investment-backed organizations to maintain physician independence.
The state’s strengthened corporate practice framework means physician groups and investors should expect continued attention to governance structures, MSO relationships, professional corporation arrangements, and contractual provisions affecting clinical authority.
California’s policy direction suggests that investment in healthcare will remain possible, but arrangements involving physician practices will face closer scrutiny when financial relationships could affect clinical independence. The April 2026 CMA court filing further demonstrates that the boundaries of these rules remain an active legal issue.
For physicians, understanding these developments is important when evaluating potential investment, acquisition, affiliation, or management arrangements.
Visit California Medical Association – Corporate Practice of Medicine and Healthcare Policy to review current physician advocacy updates, legal developments, and resources concerning corporate influence in medical practice.
Subscribe to StanfordPhysicianAdvocate.org for continuing coverage of private equity, physician autonomy, corporate practice of medicine, healthcare transactions, MSO structures, California healthcare regulation, and policy developments affecting physicians throughout 2026.